MedTrace Logo

Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males

NCT07092722 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-07-30

No results posted yet for this study

Summary

The Purpose of the study is to evaluate the efficacy of LN18178 in improving muscle strength, aerobic capacity and body composition in healthy young males.

Conditions

  • Muscle Strength Recovery
  • Endurance
  • Healthy Human Volunteers

Interventions

DIETARY_SUPPLEMENT

LN18178

400 mg, One capsule to be consumed in the morning after breakfast with water for 12 Weeks

DIETARY_SUPPLEMENT

Placebo

One capsule to be consumed in the morning after breakfast with water for 12 Weeks

Sponsors & Collaborators

  • GENCOR Lifestage Solutions

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
36 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-04
Primary Completion
2026-01-15
Completion
2026-01-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07092722 on ClinicalTrials.gov